Transcatheter aortic valve implantation and off-pump coronary artery bypass surgery: an effective hybrid procedure in selected patients†
Authors:
Open Access
- 26 February 2018
- journal article
- conference paper
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 27 (1) , 102-107
Abstract
Simultaneous surgical off-pump coronary revascularization and transcatheter aortic valve implantation (TAVI) as a hybrid procedure may be a therapeutic option for patients with a TAVI indication who are not suitable for percutaneous coronary intervention and for patients who have an indication for combined surgical aortic valve implantation and coronary artery bypass grafting but present with a porcelain aorta. Early outcomes of these patients are analysed in this study. From February 2011 to April 2017, hybrid TAVI/off-pump coronary artery bypass (OPCAB) was performed in 12 (60%) patients, hybrid TAVI/minimally invasive direct coronary artery bypass in 6 (30%) patients and staged TAVI/OPCAB in 2 (10%) patients. Endpoints of this study were 30-day mortality, device success and postoperative adverse events as defined by the updated Valve Academic Research Consortium (VARC-2). The median age at the time of surgery was 77 years [interquartile range (IQR), 70–81] with a median logistic EuroSCORE and Society of Thoracic Surgeons' Predicted Risk score of 16.1% (IQR, 9.3–28.1) and 3.9% (IQR, 2.2–5.6), respectively. The median Synergy between PCI with Taxus and Cardiac Surgery score was 16.5 (IQR, 9.8–22.8). TAVI implantation routes were transaortic in 9 (45%) patients, transapical and transfemoral in 5 (25%) patients each and trans-subclavian in 1 (5%) patient. Complete myocardial revascularization was achieved in 75% of patients. Device success rate was 100%. Paravalvular aortic regurgitation did not exceed mild in any patient. Stroke/transient ischaemic attack, vascular complications and myocardial infarction were not observed. Re-exploration for bleeding was required in 1 (5%) patient. Thirty-day mortality was 0%. Hybrid OPCAB/MIDCAB and TAVI prove to be a safe and effective alternative treatment option in selected higher risk patients.Keywords
This publication has 21 references indexed in Scilit:
- Coronary artery disease in patients undergoing TAVI: why, what, when and how to treatEuroIntervention, 2014
- Coronary artery disease severity and aortic stenosis: clinical outcomes according to SYNTAX score in patients undergoing transcatheter aortic valve implantationEuropean Heart Journal, 2014
- Complete Revascularization Is Not a Prerequisite for Success in Current Transcatheter Aortic Valve Implantation PracticeJACC: Cardiovascular Interventions, 2013
- The transaortic approach for transcatheter aortic valve implantation: a valid alternative to the transapical access in patients with no peripheral vascular option. A single center experience†European Journal of Cardio-Thoracic Surgery, 2013
- Updated standardized endpoint definitions for transcatheter aortic valve implantation: The Valve Academic Research Consortium-2 consensus documentThe Journal of Thoracic and Cardiovascular Surgery, 2013
- Guidelines on the management of valvular heart disease (version 2012)European Journal of Cardio-Thoracic Surgery, 2012
- Safety and effectiveness of a selective strategy for coronary artery revascularization before transcatheter aortic valve implantationCatheterization and Cardiovascular Interventions, 2012
- Combined Off-Pump Transapical Transcatheter Aortic Valve Implantation and Minimally Invasive Direct Coronary Artery BypassJournal of Cardiac Surgery, 2010
- Effect of Concomitant Coronary Artery Disease on Procedural and Late Outcomes of Transcatheter Aortic Valve ImplantationThe Annals of Thoracic Surgery, 2010
- Results of percutaneous and transapical transcatheter aortic valve implantation performed by a surgical team☆European Journal of Cardio-Thoracic Surgery, 2009